Andere Sprachen Wockhardt Limited

Aktien

A0DKLX

INE049B01025

WOCKPHARMA

Verzögert NSE India S.E. Andere Börsenplätze 08:15:19 14.05.2024			% 5 Tage	% 1. Jan.
544 ^INR	+1,31 %		+0,27 %	+27,57 %

03.04.	Wockhardt Limited gibt das Ausscheiden von unabhängigen Direktoren bekannt	CI
14.02.	Wockhardt Limited meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Wockhardt Limited Announces Cessation of Independent Directors	03.04.
Aziwok vs Aziwake: Delhi High Court Grants Interim Injunction In Light Of Rival Marks Being Closely Similar For Azithromycin	08.03.
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14.02.
Wockhardt Limited Announces Successful Completion of Pivotal Phase 3 Pneumonia Study of Its Macrolide Antibody Nafithromycin WCK 4873	11.12.
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14.11.
CARE Cuts Rating on Wockhardt's Working Capital to BB+; Outlook Negative	06.09.23
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14.08.23
Wockhardt Limited Announces Executive Changes	14.08.23
CARE Keeps BBB- Rating on Wockhardt's Bank Financing	07.06.23
Wockhardt Trims Consolidated Loss in Fiscal Q4	29.05.23
Wockhardt Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	26.05.23
INDIA STOCKS-Indian shares fall on rate-hike worries ahead of Fed, RBI minutes	22.02.23
Wockhardt Widens Consolidated Net Profit in Fiscal Q3	14.02.23
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13.02.23
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	04.11.22
CARE Keeps Rating on Wockhardt's Long-term Bank Financing, Bonds; Outlook Stable	05.09.22
Wockhardt : Corp Restructuring - others	20.08.22
Wockhardt Starts Global Phase 3 Clinical Study of Novel Antibiotic WCK 5222	16.08.22
Wockhardt Announces Successful Initiation of Global Phase 3 Clinical Study of Its Novel Antibiotic WCK 5222	16.08.22
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12.08.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Wockhardt Limited

Aktien

A0DKLX

INE049B01025

WOCKPHARMA

Andere Sprachen

Filter